Picard Medical (PMI) Net Margin (2024 - 2026)

Picard Medical has reported Net Margin for 3 years, with the latest figure at 662.26% in Q1 2026.

• For the quarter ending Q1 2026, Net Margin rose 36048.0% year-over-year to 662.26%; the trailing twelve-month figure through Mar 2026 stood at 530.53% (up 37544.0% YoY), and the FY2025 full-year result was 546.6%, down 602.0% from the prior year.
• Net Margin for Q1 2026 stood at 662.26%, down from 425.27% in the prior quarter.
• The five-year high for Net Margin was 315.53% in Q2 2025, with the low at 1137.44% in Q4 2024.
• Historically, Net Margin has averaged 737.98% across 3 years, with a median of 731.11% in 2024.
• The largest YoY upside for Net Margin was 71217 bps in 2025 against a maximum downside of 9640 bps in 2025.
• Picard Medical's Net Margin stood at 1137.44% in 2024, then soared by 63 bps to 425.27% in 2025, then plunged by 56 bps to 662.26% in 2026.
• The last three Net Margin figures came in at 662.26% (Q1 2026), 425.27% (Q4 2025), and 878.35% (Q3 2025), per Business Quant data.